1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Swedencare AB (publ)

Swedencare AB (publ)

SECARE.ST
Swedencare AB (publ)SE flagStockholm Stock Exchange
25.45
SEK
-0.35
- -
4.07BMarket Cap
Swedencare AB (publ)
SECARE.ST
(Stockholm Stock Exchange)

Recent

price

25.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.31
0.5
0.77
1.08
1.26
1.61
2.76
6.88
11.87
14.73
15.93
16.81
16.36
Revenue per Share
0.05
0.12
0.14
0.22
0.3
0.38
0.38
0.49
0.61
0.37
0.62
0.35
0.41
Basic EPS, GAAP
0.06
0.05
0.03
0.15
0.16
0.36
0.41
0.88
1.19
2.57
1.81
1.73
1.83
Free Cash Flow per Basic Share
- -
0.03
- -
- -
- -
- -
0.13
0.15
0.2
0.22
0.23
0.25
0.25
Dividend per Share
- -
0.24
0.81
0.88
0.01
1.05
1.2
1.27
1.32
1.44
1.83
1.92
0.01
Book Value per Share
0.07
0.22
0.09
0.3
0.61
1
2.43
-3.1
-5.85
-4.42
-2.96
-6.09
-6.81
Tangible Book Value per Share
77
55
70
79
79
79
87
112
155
159
159
160
159
Basic Weighted Avg Shares
24
27
54
85
99
127
240
770
1,843
2,338
2,530
2,683
2,603
Sales/Revenue/Turnover
18.85
31.8
21.65
25.61
28.85
29.04
17.12
8.39
6.52
7.63
8.77
5.09
6.76
Operating Margin (%)
- -
- -
2
1
1
3
13
73
269
310
316
311
310
Depreciation Expense
4
7
10
17
23
30
33
55
94
59
99
56
65
Net Income, GAAP
23.56
22.58
17.63
20.5
19.83
18.47
16.03
4.01
- -
27.74
34.29
32.73
41.24
Effective Tax Rate (%)
14.55
24.59
18.06
19.9
23.46
23.6
13.9
7.09
5.13
2.51
3.91
2.07
2.49
Profit Margin (%)
9
11
21
30
38
64
335
337
697
694
774
685
772
Working Capital
- -
- -
17
9
2
2
139
704
1,867
1,626
1,427
1,756
1,774
LT Debt
5
13
57
74
98
131
918
2,420
7,461
7,207
8,032
6,665
6,923
Total Equity
- -
62.46
19.35
19.38
22.14
23.8
5.52
2.9
- -
1.4
1.57
1
1.13
Return on Invested Capital (%)
- -
101.84
21.01
20.73
48.26
61.55
18.86
11.04
- -
6.3
8.37
4.89
6.32
Return on Capital (%)
- -
101.65
28.01
27.07
66.81
71.55
35.74
44.5
54.54
27.04
38.07
18.58
4,050
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
43
40
40
LT Borrowings
1,247
1,703
1,774
LT Finance Leases
180
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
159
159
160
Market Capitalization
7,660
6,032
6,897

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,170
1,458
1,161
Cash, Cash Equivalents & STI
187
527
124
Accounts Receivable, Net
293
291
294
Inventories
476
465
562
Total Current Liabilities
396
397
389
Payables & Accruals
- -
- -
- -
ST Debt
43
40
40
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
138.96%
72.57%
-17.02%
Free Cash Flow
100.28%
70.28%
-4.24%
Net Income, GAAP
32.08%
24.73%
-43.88%
Sales/Revenue/Turnover
69.17%
80.29%
6.04%
Total Cash Common Dividend
- -
32.86%
9.59%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
599
632
644
665
2,530
2025
646
649
685
- -
2,683
2026
655
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.19
0.13
0.15
0.15
0.62
2025
0.15
-0.04
0.1
- -
0.35
2026
0.11
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.23
- -
- -
0.23
2025
- -
0.25
- -
- -
0.25
2026
- -
- -
- -
- -
- -
Similar Companies
Green Scientific Labs Holdings Inc. (GSL.CN)
Caplin Point Laboratories Limited (CAPPL.BO)
North China Pharmaceutical Company Ltd. (600812.SS)
Canopy Growth Corporation (CGC)
Orexo AB (publ) (ORXOF)
Celltrion Pharm, Inc. (068760.KQ)
Business
Swedencare AB (publ) (SECARE.ST) develops, manufactures and markets premium pet health products, with a focus on nutritional supplements, oral care, dermatology, joint support, digestive health and grooming solutions for dogs, cats and horses. The company offers a broad portfolio of branded products including ProDen PlaqueOff®, the original seaweed-based dental health solution; NaturVet® soft chews and supplements; Innovet science-based premium formulations; Pet MD® online-targeted supplements and topicals; Rx Vitamins®; nutravet®; Rileys® Organics; Healthy Breeds animal nutritional supplements, treats and grooming items; as well as offerings from NutriScience, Summit Veterinary Pharmaceuticals, Vet Worthy and Healthy Solutions for Pets; distributed through veterinarians, pet stores, pharmacies, e-commerce platforms such as Amazon, Chewy and zooplus, and direct-to-consumer channels. Founded in 2000 and headquartered in Malmö, Sweden, Swedencare operates globally across approximately 70 countries with subsidiaries and production facilities primarily in Europe and North America, targeting premium segments in the veterinary supplies and pharmaceuticals industry. Recent developments include the 2025 acquisitions of Summit Veterinary Pharmaceuticals in the UK, Pack Approved assets, NaturVet's Amazon account, and earlier brand purchases such as Riley's Organics, Vet Worthy and Healthy Solutions for Pets; a directed new share issue raising SEK 3.6 billion to finance expansions; investments in manufacturing capacity at Vetio facilities for soft chews, treats and liquids; and strengthened US market presence through Walmart store expansions and organizational enhancements in veterinary and e-commerce channels.